Southeast Xlerator Network

东南XLerator网络建议建立一个网络化的，易于访问的区域 技术转让加速器中心（“XLerator Hub”或“Hub”），以分享最佳做法， 传播教育内容，提供产品、服务、设施和其他资源 通过实体和在线平台为东南部的创新者和受训者建立联系 IDEA表示。由XLerateHealth，LLC领导，这是一项以医疗保健为重点的技术， 加速器，该中心将1）弥合伟大的想法和市场之间的鸿沟， 利用和连接所有参与方的现有资源和独特的专业知识资产 东南部IDEA州地区的实体，2）填补了构成有效障碍的空白 合作机构之间的商业化，以及3）提供必要的资源，教育， 和商业网络，以促进和维持整个地区的创业文化。这 该项目将解决重大差距和缺乏获得资源、人才和资本的机会， 生物医学技术的各自地方商业化生态系统， 在东南部的IDEA州地区，使技术转让的速度， 该地区学术研究发现的商业化程度不高。轮毂 目标/核心职能是： 1.提高创新者对技术如何 推向市场。 2.通过加速器和技术转让办公室提高知识和理解 各种生物医学技术的独特商业化途径 3.促进获得技术/产品开发和商业化资源 前期技术进步和后期产品开发所需 4.帮助缩小基础研究发现和科学研究发现之间的资金差距 可行性证明，以及（B）在赠款资金和私人资本耗尽之间 创造产品和收入。 5.将制药、医疗器械、医疗保健IT和 电子和其他生物医学技术，通过创业，许可证和 与成熟的公司建立伙伴关系，并将中心的 平台、方案和材料通过其他地区的访问。 该中心的影响将是增加市场准备的技术和专利，更成功 创业公司，并增加生物医学技术的加速。

The Southeast XLerator Network proposes to create a networked and easily accessible regional technology transfer accelerator hub (“XLerator Hub” or “Hub”) to share best practices, disseminate education content, and offer products, services, facilities and other resources connected through both physical and online platforms for innovators and trainees in the Southeast IDeA states. Led by XLerateHealth, LLC, an SBA award-winning healthcare-focused technology accelerator, the Hub will 1) bridge the divide between great ideas and the marketplace by leveraging and connecting existing resources and unique expertise assets across all participating entities in the Southeast IDeA state region, 2) fill the gaps that constitute barriers to efficient commercialization among partner institutions, and 3) deliver the necessary resources, education, and business networks to foster and sustain a culture of entrepreneurship across the region. This project will address significant disparities and lack of access to resources, talent and capital in respective local commercialization ecosystems for biomedical technologies that are pervasive across the Southeast IDeA state region, making the rates of technology transfer and commercialization of academic research discoveries in this region suboptimal. The Hub objectives/ core functions are: 1. To improve knowledge and understanding by innovators about how technologies are brought to market. 2. To improve knowledge and understanding by accelerators and technology transfer offices about the unique commercialization pathways of various biomedical technologies 3. To facilitate access to technology/product development and commercialization resources required for early-stage technology advancement and later-stage product development 4. To help close the gap(s) in funding (a) between basic research discoveries and scientific proof of feasibility, and (b) between exhaustion of grant funding and private capital required to generate products and revenues. 5. To commercialize new innovation in pharmaceuticals, medical devices, healthcare IT and electronics, and other biomedical technologies through entrepreneurship, licensing and partnerships with established companies, and additionally commercialize the Hub’s platform, programs, and materials through access by other regions. The impact of the Hub will be increased market-ready technologies and patents, more successful startups, and increased biomedical technology acceleration.